$ALGM

Hagen Erin sold $101K of ALGM

Hagen Erin (SVP, CHRO) sold 2,285 shares of ALLEGRO MICROSYSTEMS, INC. (ALGM) at $44.39 ($0.10M total) on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hagen Erin
Published Aug 12, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALGM
Neutral
medium confidence
Mentioned
$ALGM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALGMNeutralLow
01

Why it matters

The only new information is the specific sale details (shares, price, total value) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 structure reduces interpretive weight versus discretionary selling.

03

What to watch

The filing does not indicate whether other insiders sold/bought around the same window, nor does it provide any new guidance or business developments.

Relevance 3/10Novelty 3/10Timing: filed Aug. 12 after-hours; sale executed Aug. 10

Background

The article is a SEC Form 4 insider transaction disclosure for Allegro Microsystems, Inc. (ALGM).

Company-level read

Ticker impact

$ALGMNeutralMedium confidence
Context

ALGM disclosed a Form 4 showing SVP CHRO Hagen Erin sold 2,285 shares at $44.39 on Aug. 10 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by other company-specific news.

Evidence & confidence

The filing provides transaction size, price, and 10b5-1 status, but no new operational, financial, or regulatory information about ALGM.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

10b5-1 sales can coincide with routine liquidity needs and do not necessarily reflect bearish views; the market may overreact to the headline.

Key entities

  • ALLEGRO MICROSYSTEMS, INC.

    Subject of the Form 4 insider transaction disclosure.

  • Hagen Erin

    SVP, CHRO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALGMMedAI 8/10

Allegro Microsystems Inc (ALGM) (Q2 2027) Earnings Call Highlights: Record Industrial Sales

Allegro Microsystems (ALGM) reported Q2 2027 earnings, highlighting record industrial sales but noting capacity constraints, data center growth moderation, and automotive customer caution. CEO Michael Doogue and CFO Derek D'Antilio discussed capacity plans, pricing strategies, and inventory levels. The company expects gross margin improvements and sees potential for growth exceeding mid-teens targets.

$ALGMHighAI 8/10

Allegro (ALGM) Q2 2027 Earnings Call Transcript

Allegro (ALGM) reported Q2 2027 sales of $277M, up 29% YoY, and non-GAAP EPS of $0.26, doubling YoY. The company saw record design wins, up 40% YoY, and bookings up 45% YoY. Automotive sales grew 11% YoY, with key wins in xEV and ADAS systems. Industrial and data center sales also hit records, with data center sales up 150% YoY. The company expects continued growth driven by strategic design wins and market trends.

$ALGMMed

What Allegro MicroSystems (ALGM) Said on Its Q2 Earnings Call

Allegro MicroSystems (ALGM) reported Q2 revenue growth, with industrial sales at $104M (up 11% sequentially, 79% YoY) and data center revenue at $46M (up 150% YoY). Management expects data center sales to more than double by fiscal 2027. Gross margin was 51.5%, up 40 bps sequentially. Q3 guidance: revenue $278M-$288M (23% YoY growth), gross margin 51.5%-52.5%, EPS $0.25-$0.29 (80% YoY growth).